{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:05:29Z","timestamp":1780625129510,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UK Ministry of Defence"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s10096-016-2754-1","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T08:16:48Z","timestamp":1475741808000},"page":"2015-2024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mitogen-activated protein kinases (MAPKs) are modulated during Francisella tularensis infection, but inhibition of extracellular-signal-regulated kinases (ERKs) is of limited therapeutic benefit"],"prefix":"10.1007","volume":"35","author":[{"given":"R. J.","family":"Saint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. V.","family":"D\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. C.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,6]]},"reference":[{"key":"2754_CR1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3. Nature 413:732\u2013738","journal-title":"Nature"},{"key":"2754_CR2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","volume":"130","author":"MS Jin","year":"2007","unstructured":"Jin MS, Kim SE, Heo JY, Lee ME, Kim HM et al (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071\u20131082","journal-title":"Cell"},{"key":"2754_CR3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/IAI.69.3.1477-1482.2001","volume":"69","author":"M Hirschfeld","year":"2001","unstructured":"Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ et al (2001) Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69:1477\u20131482","journal-title":"Infect Immun"},{"key":"2754_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00418-003-0497-4","volume":"119","author":"D Droemann","year":"2003","unstructured":"Droemann D, Goldmann T, Branscheid D, Clark R, Dalhoff K et al (2003) Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem Cell Biol 119:103\u2013108","journal-title":"Histochem Cell Biol"},{"key":"2754_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.14712\/fb2005051060188","volume":"51","author":"F Sandor","year":"2005","unstructured":"Sandor F, Buc M (2005) Toll-like receptors. II. Distribution and pathways involved in TLR signalling. Folia Biol 51:188\u2013197","journal-title":"Folia Biol"},{"key":"2754_CR6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.00636-12","volume":"20","author":"RV D\u2019Elia","year":"2013","unstructured":"D\u2019Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC (2013) Targeting the \u201ccytokine storm\u201d for therapeutic benefit. Clin Vaccine Immunol 20:319\u2013327","journal-title":"Clin Vaccine Immunol"},{"key":"2754_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01885-12","author":"RV D\u2019Elia","year":"2013","unstructured":"D\u2019Elia RV, Laws TR, Carter A, Lukaszewski R, Clark GC (2013) Targeting the \u201cRising DAMP\u201d during a Francisella tularensis infection. Antimicrob Agents Chemother. doi: 10.1128\/AAC.01885-12","journal-title":"Antimicrob Agents Chemother"},{"key":"2754_CR8","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.4049\/jimmunol.180.11.7574","volume":"180","author":"A Lembo","year":"2008","unstructured":"Lembo A, Pelletier M, Iyer R, Timko M, Dudda JC et al (2008) Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. J Immunol 180:7574\u20137581","journal-title":"J Immunol"},{"key":"2754_CR9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1189\/jlb.0111014","volume":"90","author":"LE Cole","year":"2011","unstructured":"Cole LE, Mann BJ, Shirey KA, Richard K, Yang Y et al (2011) Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge. J Leukoc Biol 90:787\u2013797","journal-title":"J Leukoc Biol"},{"key":"2754_CR10","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1128\/IAI.02030-05","volume":"74","author":"M Malik","year":"2006","unstructured":"Malik M, Bakshi CS, Sahay B, Shah A, Lotz SA et al (2006) Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect Immun 74:3657\u20133662","journal-title":"Infect Immun"},{"key":"2754_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1574-695X.1996.tb00243.x","volume":"13","author":"A Macela","year":"1996","unstructured":"Macela A, Stulik J, Hernychova L, Kroca M, Krocova Z et al (1996) The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice. FEMS Immunol Med Microbiol 13:235\u2013238","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2754_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.micpath.2004.06.010","volume":"37","author":"WX Chen","year":"2004","unstructured":"Chen WX, KuoLee R, Shen H, Busa M, Conlan JW (2004) Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis. Microb Pathog 37:185\u2013191","journal-title":"Microb Pathog"},{"key":"2754_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.imlet.2004.10.001","volume":"97","author":"WX Chen","year":"2005","unstructured":"Chen WX, KuoLee R, Shen H, Busa M, Conlan JW (2005) Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with Francisella tularensis LVS. Immunol Lett 97:151\u2013154","journal-title":"Immunol Lett"},{"key":"2754_CR14","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.4049\/jimmunol.180.10.6885","volume":"180","author":"LE Cole","year":"2008","unstructured":"Cole LE, Santiago A, Barry E, Kang TJ, Shirey KA et al (2008) Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways. J Immunol 180:6885\u20136891","journal-title":"J Immunol"},{"key":"2754_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.micpath.2005.02.003","volume":"38","author":"M Telepnev","year":"2005","unstructured":"Telepnev M, Golovliov I, Sjostedt A (2005) Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb Pathog 38:239\u2013247","journal-title":"Microb Pathog"},{"key":"2754_CR16","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1128\/IAI.00561-07","volume":"75","author":"KJ Hong","year":"2007","unstructured":"Hong KJ, Wickstrum JR, Yeh HW, Parmely MJ (2007) Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes. Infect Immun 75:5338\u20135345","journal-title":"Infect Immun"},{"key":"2754_CR17","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.4049\/jimmunol.176.11.6888","volume":"176","author":"LE Cole","year":"2006","unstructured":"Cole LE, Elkins KL, Michalek SM, Qureshi N, Eaton LJ et al (2006) Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J Immunol 176:6888\u20136899","journal-title":"J Immunol"},{"key":"2754_CR18","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/IAI.01868-06","volume":"75","author":"LE Cole","year":"2007","unstructured":"Cole LE, Shirey KA, Barry E, Santiago A, Rallabhandi P et al (2007) Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect Immun 75:4127\u20134137","journal-title":"Infect Immun"},{"key":"2754_CR19","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1074\/jbc.M706854200","volume":"283","author":"S Thakran","year":"2008","unstructured":"Thakran S, Li HF, Lavine CL, Miller MA, Bina JE et al (2008) Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR)2\/TLR1 heterodimer. J Biol Chem 283:3751\u20133760","journal-title":"J Biol Chem"},{"key":"2754_CR20","doi-asserted-by":"crossref","first-page":"e0127278","DOI":"10.1371\/journal.pone.0127278","volume":"10","author":"MG Ghonime","year":"2015","unstructured":"Ghonime MG, Mitra S, Eldomany RA, Wewers MD, Gavrilin MA (2015) Inflammasome priming is similar for francisella species that differentially induce inflammasome activation. PLoS One 10:e0127278","journal-title":"PLoS One"},{"key":"2754_CR21","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4049\/jimmunol.162.4.2291","volume":"162","author":"KL Elkins","year":"1999","unstructured":"Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM (1999) Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 162:2291\u20132298","journal-title":"J Immunol"},{"key":"2754_CR22","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/IAI.00736-09","volume":"78","author":"RB Pyles","year":"2010","unstructured":"Pyles RB, Jezek GE, Eaves-Pyles TD (2010) Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection. Infect Immun 78:1700\u20131710","journal-title":"Infect Immun"},{"key":"2754_CR23","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/j.molimm.2008.01.011","volume":"45","author":"KVL Parsa","year":"2008","unstructured":"Parsa KVL, Butchar JP, Rajaram MVS, Cremer TJ, Tridandapani S (2008) The tyrosine kinase Syk promotes phagocytosis of Francisella through the activation of Erk. Mol Immunol 45:3012\u20133021","journal-title":"Mol Immunol"},{"key":"2754_CR24","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1074\/jbc.M115.681478","volume":"291","author":"SM Rabadi","year":"2016","unstructured":"Rabadi SM, Sanchez BC, Varanat M, Ma Z, Catlett SV et al (2016) Antioxidant defenses of Francisella tularensis modulate macrophage function and production of proinflammatory cytokines. J Biol Chem 291:5009\u20135021","journal-title":"J Biol Chem"},{"key":"2754_CR25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.molimm.2008.08.281","volume":"46","author":"P Zhang","year":"2009","unstructured":"Zhang P, Katz J, Michalek SM (2009) Glycogen synthase kinase-3 beta (GSK3 beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol Immunol 46:677\u2013687","journal-title":"Mol Immunol"},{"key":"2754_CR26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","volume":"68","author":"PP Roux","year":"2004","unstructured":"Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320\u2013344","journal-title":"Microbiol Mol Biol Rev"},{"key":"2754_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9\u201318","journal-title":"Cell Res"},{"key":"2754_CR28","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1016\/j.bmcl.2008.10.054","volume":"18","author":"SD Barrett","year":"2008","unstructured":"Barrett SD, Bridges AJ, Dudley DT, Saltiel AR, Fergus JH et al (2008) The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorg Med Chem Lett 18:6501\u20136504","journal-title":"Bioorg Med Chem Lett"},{"key":"2754_CR29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.coph.2005.04.007","volume":"5","author":"N Thompson","year":"2005","unstructured":"Thompson N, Lyons J (2005) Recent progress in targeting the Raf\/MEK\/ERK pathway with inhibitors in cancer drug discovery. Curr Opin Pharmacol 5:350\u2013356","journal-title":"Curr Opin Pharmacol"},{"key":"2754_CR30","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1016\/j.vaccine.2008.09.077","volume":"26","author":"GR Klimpel","year":"2008","unstructured":"Klimpel GR, Eaves-Pyles T, Moen ST, Taormina J, Peterson JW et al (2008) Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Vaccine 26:6874\u20136882","journal-title":"Vaccine"},{"key":"2754_CR31","doi-asserted-by":"crossref","first-page":"e7920","DOI":"10.1371\/journal.pone.0007920","volume":"4","author":"AL Abplanalp","year":"2009","unstructured":"Abplanalp AL, Morris IR, Parida BK, Teale JM, Berton MT (2009) TLR-dependent control of Francisella tularensis infection and host inflammatory responses. PLoS ONE 4:e7920","journal-title":"PLoS ONE"},{"key":"2754_CR32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.micinf.2004.12.020","volume":"7","author":"R Hrstka","year":"2005","unstructured":"Hrstka R, Stulik J, Vojtesek B (2005) The role of MAPK signal pathways during Francisella tularensis LVS infection-induced apoptosis in murine macrophages. Microbes Infect 7:619\u2013625","journal-title":"Microbes Infect"},{"key":"2754_CR33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00284-011-9985-2","volume":"63","author":"K Du","year":"2011","unstructured":"Du K, Zheng Q, Zhou M, Zhu L, Ai B et al (2011) Chlamydial antiapoptotic activity involves activation of the Raf\/MEK\/ERK survival pathway. Curr Microbiol 63:341\u2013346","journal-title":"Curr Microbiol"},{"key":"2754_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","volume":"277","author":"S Cagnol","year":"2010","unstructured":"Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death\u2014apoptosis, autophagy and senescence. FEBS J 277:2\u201321","journal-title":"FEBS J"},{"key":"2754_CR35","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.71.8.4642-4646.2003","volume":"71","author":"XH Lai","year":"2003","unstructured":"Lai XH, Sjostedt A (2003) Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages. Infect Immun 71:4642\u20134646","journal-title":"Infect Immun"},{"key":"2754_CR36","doi-asserted-by":"crossref","first-page":"20343","DOI":"10.1074\/jbc.M110.116988","volume":"285","author":"M Asim","year":"2010","unstructured":"Asim M, Chaturvedi R, Hoge S, Lewis ND, Singh K et al (2010) Helicobacter pylori induces ERK-dependent formation of a Phospho-c-Fos.c-Jun activator protein-1 complex that causes apoptosis in macrophages. J Biol Chem 285:20343\u201320357","journal-title":"J Biol Chem"},{"key":"2754_CR37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1189\/jlb.0309119","volume":"86","author":"SC Cowley","year":"2009","unstructured":"Cowley SC (2009) Proinflammatory cytokines in pneumonic tularemia: too much too late? J Leukoc Biol 86:469\u2013470","journal-title":"J Leukoc Biol"},{"key":"2754_CR38","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.1003445","volume":"188","author":"A Leelahavanichkul","year":"2012","unstructured":"Leelahavanichkul A, Bocharov AV, Kurlander R, Baranova IN, Vishnyakova TG et al (2012) Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J Immunol 188:2749\u20132758","journal-title":"J Immunol"},{"key":"2754_CR39","first-page":"341","volume":"64","author":"DL Fritz","year":"2014","unstructured":"Fritz DL, England MJ, Miller L, Waag DM (2014) Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B. Comp Med 64:341\u2013350","journal-title":"Comp Med"},{"key":"2754_CR40","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/iai.64.8.3288-3293.1996","volume":"64","author":"KL Elkins","year":"1996","unstructured":"Elkins KL, RhinehartJones TR, Culkin SJ, Yee D, Winegar RK (1996) Minimal requirements for murine resistance to infection with Francisella tularesis LVS. Infect Immun 64:3288\u20133293","journal-title":"Infect Immun"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2754-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2754-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2754-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T01:38:53Z","timestamp":1749605933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2754-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,6]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2754"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2754-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,6]]}}}